← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
GNT
GAMCO Natural Resources, Gold & Income Trust
Valuation N/A
Unknown
Price$9.08
Model IV—
P/IV—
Limited data — see page
GNTA
Genenta Science S.p.A.
Valuation N/A
Healthcare Risk 40 · Elevated
Price$0.83
Model IV—
P/IV—
Limited data — see page
GOF
GUGGENHEIM STRATEGIC OPPORTUNITIES FUND
Valuation N/A
Unknown
Price$9.18
Model IV—
P/IV—
Limited data — see page
GOGO
Gogo Inc.
Valuation N/A
Communication Services Risk 66 · High
Price$2.62
Model IV—
P/IV—
Market implies -50.0%/yr vs model +22.2% · below model
GOLD
Gold.com, Inc.
Valuation N/A
Industrials Risk 30 · Moderate
Price$48.22
Model IV—
P/IV—
Market implies +14.3%/yr vs model +8.5% · above model
GOOGL
Alphabet Inc.
Valuation N/A
Technology Risk 36 · Moderate
Price$349.39
Model IV—
P/IV—
Market implies +31.4%/yr vs model +11.9% · above model
GOOS
Canada Goose Holdings Inc.
Valuation N/A
Consumer Cyclical
Price$7.93
Model IV—
P/IV—
Limited data — see page
GP
GREENPOWER MOTOR Co INC.
Valuation N/A
Consumer Cyclical Risk 30 · Moderate
Price$0.75
Model IV—
P/IV—
Limited data — see page
GPAC
General Purpose Acquisition Corp.
Valuation N/A
Financial Services
Price$10.07
Model IV—
P/IV—
Limited data — see page
GPAT
GP-Act III Acquisition Corp.
Valuation N/A
Financial Services
Price$10.97
Model IV—
P/IV—
Limited data — see page
GPCR
Structure Therapeutics Inc.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$38.66
Model IV—
P/IV—
Limited data — see page
GPGI
GPGI, Inc.
Valuation N/A
Financial Services Risk 51 · Elevated
Price$12.98
Model IV—
P/IV—
Market implies +132.4%/yr vs model +2.0% · above model
GPJA
GEORGIA POWER CO
Valuation N/A
Utilities
Price$19.79
Model IV—
P/IV—
Limited data — see page
GPRK
GeoPark Ltd
Valuation N/A
Energy Risk 32 · Moderate
Price$11.47
Model IV—
P/IV—
Limited data — see page
GRAB
Grab Holdings Ltd
Valuation N/A
Technology
Price$3.05
Model IV—
P/IV—
Limited data — see page
GRAF
Graf Global Corp.
Valuation N/A
Financial Services Risk 31 · Moderate
Price$10.88
Model IV—
P/IV—
Limited data — see page
GRAL
GRAIL, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$76.23
Model IV—
P/IV—
Market implies +52.6%/yr vs model +25.7% · above model
GRCE
Grace Therapeutics, Inc.
Valuation N/A
Healthcare Risk 27 · Moderate
Price$2.22
Model IV—
P/IV—
Market implies -18.8%/yr vs model +15.0% · below model
GRDN
Guardian Pharmacy Services, Inc.
Valuation N/A
Consumer Cyclical
Price$43.64
Model IV—
P/IV—
Limited data — see page
GRDX
GridAI Technologies Corp.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$2.86
Model IV—
P/IV—
Market implies +59.5%/yr vs model +15.0% · above model
GREE
Greenidge Generation Holdings Inc.
Valuation N/A
Financial Services Risk 62 · High
Price$2.10
Model IV—
P/IV—
Market implies +2.3%/yr vs model +2.0% · in line
GREEL
Greenidge Generation Holdings Inc.
Valuation N/A
Financial Services Risk 64 · High
Price$25.01
Model IV—
P/IV—
Market implies +38.1%/yr vs model +2.0% · above model
GRF
EAGLE CAPITAL GROWTH FUND, INC.
Valuation N/A
Unknown
Price$10.42
Model IV—
P/IV—
Limited data — see page
GRFS
Grifols SA
Valuation N/A
Healthcare
Price$7.48
Model IV—
P/IV—
Limited data — see page
GRI
GRI Bio, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$1.89
Model IV—
P/IV—
Limited data — see page
GRML
Greenland Mines Ltd
Valuation N/A
Healthcare Risk 31 · Moderate
Price$3.15
Model IV—
P/IV—
Limited data — see page
GRNQ
Greenpro Capital Corp.
Valuation N/A
Industrials Risk 40 · Elevated
Price$12.70
Model IV—
P/IV—
Market implies +55.2%/yr vs model +2.0% · above model
GRO
Brazil Potash Corp.
Valuation N/A
Basic Materials Risk 32 · Moderate
Price$2.41
Model IV—
P/IV—
Limited data — see page
GROV
Grove Collaborative Holdings, Inc.
Valuation N/A
Consumer Cyclical Risk 36 · Moderate
Price$1.01
Model IV—
P/IV—
Market implies -16.8%/yr vs model +2.0% · below model
GROW
U S GLOBAL INVESTORS INC
Valuation N/A
Financial Services Risk 51 · Elevated
Price$2.96
Model IV—
P/IV—
Market implies +21.7%/yr vs model +2.0% · above model
GROY
Gold Royalty Corp.
Valuation N/A
Basic Materials Risk 40 · Elevated
Price$3.41
Model IV—
P/IV—
Limited data — see page
GRPN
Groupon, Inc.
Valuation N/A
Technology Risk 60 · High
Price$18.73
Model IV—
P/IV—
Market implies +29.6%/yr vs model -7.1% · above model
GRRR
Gorilla Technology Group Inc.
Valuation N/A
Technology Risk 41 · Elevated
Price$13.59
Model IV—
P/IV—
Limited data — see page
GRVY
GRAVITY Co., Ltd.
Valuation N/A
Technology Risk 36 · Moderate
Price$71.29
Model IV—
P/IV—
Market implies +19.1%/yr vs model +2.0% · above model
GRX
Gabelli Healthcare & WellnessRx Trust
Valuation N/A
Unknown
Price$9.72
Model IV—
P/IV—
Limited data — see page
GS
GOLDMAN SACHS GROUP INC
Valuation N/A
Financial Services Risk 38 · Moderate
Price$1,029.18
Model IV—
P/IV—
Market implies +57.0%/yr vs model +2.0% · above model
GSG
iShares S&P GSCI Commodity-Indexed Trust
Valuation N/A
Financial Services Risk 32 · Moderate
Price$36.47
Model IV—
P/IV—
Limited data — see page
GSHR
Gesher Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.55
Model IV—
P/IV—
Limited data — see page
GSIT
GSI TECHNOLOGY INC
Valuation N/A
Technology Risk 44 · Elevated
Price$5.11
Model IV—
P/IV—
Market implies +57.6%/yr vs model +2.0% · above model
GSIW
Garden Stage Ltd
Valuation N/A
Financial Services Risk 37 · Moderate
Price$14.35
Model IV—
P/IV—
Market implies +71.4%/yr vs model +33.3% · above model
GSK
GSK plc
Valuation N/A
Healthcare Risk 38 · Moderate
Price$50.05
Model IV—
P/IV—
Limited data — see page
GSM
Ferroglobe PLC
Valuation N/A
Basic Materials Risk 35 · Moderate
Price$4.22
Model IV—
P/IV—
Limited data — see page
GSOL
Grayscale Solana Staking ETF
Valuation N/A
Financial Services Risk 32 · Moderate
Price$7.73
Model IV—
P/IV—
Limited data — see page
GSRF
GSR IV Acquisition Corp.
Valuation N/A
Financial Services
Price$10.23
Model IV—
P/IV—
Limited data — see page
GSRFR
GSR IV Acquisition Corp.
Valuation N/A
Financial Services
Price$1.90
Model IV—
P/IV—
Limited data — see page
GSUI
Grayscale Sui Staking ETF
Valuation N/A
Financial Services Risk 32 · Moderate
Price$10.52
Model IV—
P/IV—
Limited data — see page
GSUN
Golden Sun Technology Group Ltd.
Valuation N/A
Consumer Defensive Risk 36 · Moderate
Price$0.23
Model IV—
P/IV—
Market implies -50.0%/yr vs model +24.0% · below model
GTBP
GT Biopharma, Inc.
Valuation N/A
Healthcare Risk 37 · Moderate
Price$11.63
Model IV—
P/IV—
Limited data — see page
GTEN
Gores Holdings X, Inc. / CI
Valuation N/A
Financial Services
Price$10.55
Model IV—
P/IV—
Limited data — see page
GTERA
Globa Terra Acquisition Corp
Valuation N/A
Financial Services
Price$10.42
Model IV—
P/IV—
Limited data — see page
GTERR
Globa Terra Acquisition Corp
Valuation N/A
Financial Services
Price$0.07
Model IV—
P/IV—
Limited data — see page
GTERU
Globa Terra Acquisition Corp
Valuation N/A
Financial Services
Price$10.50
Model IV—
P/IV—
Limited data — see page
GTERW
Globa Terra Acquisition Corp
Valuation N/A
Financial Services
Price$0.05
Model IV—
P/IV—
Limited data — see page
GTLB
Gitlab Inc.
Valuation N/A
Technology Risk 27 · Moderate
Price$49.25
Model IV—
P/IV—
Market implies +69.8%/yr vs model +25.0% · above model
GUG
Guggenheim Active Allocation Fund
Valuation N/A
Unknown
Price$15.00
Model IV—
P/IV—
Limited data — see page
GUT
GABELLI UTILITY TRUST
Valuation N/A
Unknown
Price$6.41
Model IV—
P/IV—
Limited data — see page
GUTS
FRACTYL HEALTH, INC.
Valuation N/A
Healthcare Risk 35 · Moderate
Price$0.64
Model IV—
P/IV—
Market implies +98.7%/yr vs model +15.0% · above model
GXRP
Grayscale XRP Trust ETF
Valuation N/A
Financial Services Risk 37 · Moderate
Price$26.37
Model IV—
P/IV—
Limited data — see page
H
Hyatt Hotels Corp
Valuation N/A
Consumer Cyclical Risk 64 · High
Price$163.07
Model IV—
P/IV—
Market implies +42.1%/yr vs model +21.1% · above model
HACQ
HCM IV Acquisition Corp.
Valuation N/A
Financial Services
Price$10.08
Model IV—
P/IV—
Limited data — see page